Helus Pharma Inc.
HELP | NASDAQ
$10.60
-$0.11 (-1.03%)
At close: Oct 30, 2026, 4:00 PM ET
$10.81
+$0.21 (+1.98%)
Pre-market:
Nov 2, 2026, 7:17 AM ET
TTM Period Ending | Q1 2027 Jun 30, 2026 | Q4 2026 Mar 31, 2026 | Q3 2026 Dec 31, 2025 | Q2 2026 Sep 30, 2025 | Q1 2026 Jun 30, 2025 | Q4 2025 Mar 31, 2025 | Q3 2025 Dec 31, 2024 | Q2 2025 Sep 30, 2024 | Q1 2025 Jun 30, 2024 | Q4 2024 Mar 31, 2024 | Q3 2024 Dec 31, 2023 | Q2 2024 Sep 30, 2023 | Q1 2024 Jun 30, 2023 | Q4 2023 Mar 31, 2023 | Q3 2023 Dec 31, 2022 | Q2 2023 Sep 30, 2022 | Q1 2023 Jun 30, 2022 | Q4 2022 Mar 31, 2022 | Q3 2022 Dec 31, 2021 | Q2 2022 Sep 30, 2021 | Q1 2022 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -182.62M | -154.08M | -138.31M | -106.52M | -116.39M | -109.15M | -99.92M | -119.41M | -74.4M | -78.08M | -70.45M | -50.87M | -48.95M | -47.49M | -51.87M | -58.34M | -65.97M | -67.63M | -63.31M | -57.52M | -39.96M |
Depreciation & Amortization | 123.21K | 120.89K | 152.32K | 265.52K | 367.57K | 440.68K | 520.68K | 527.5K | 456K | 424K | 350K | 279K | 267K | 251K | 227K | 200K | 183K | 168K | 160.06K | 129.06K | 87.06K |
Stock-Based Compensation | 5M | 5.55M | 7.64M | 6.61M | 39.37M | 41.72M | 40.9M | 47.39M | 15.52M | 13.89M | 13.1M | 4.15M | 3.81M | 4.69M | 7.55M | 11.03M | 15.41M | 18.03M | 18.75M | 18.51M | 13.05M |
Other Working Capital | 39.23K | -1.88M | 3.03M | -2.94M | 2.5M | -4.28M | -11.08M | -19.15M | -14.23M | -3.94M | -3.34M | 4.66M | 170K | -489K | -152K | -997K | 510K | 986K | -1.15M | -1.05M | 566.39K |
Other Non-Cash Items | 25.66M | 12.93M | 5.88M | -14.14M | -20.35M | -21.37M | -22.73M | -455.49K | -4.44M | -111K | 2.63M | -1.15M | -1.34M | -3.44M | -1.64M | 306K | 2.99M | 4.01M | 4.93M | 4.16M | 3.65M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.14M | -3.06M | 1.81M | -3.85M | 1.52M | -5.32M | -12.04M | -20.63M | -15.23M | -5.03M | -4.66M | 3.82M | -777K | -1.44M | -582K | -1.56M | -79K | 213K | -2.59M | -3.01M | -788.82K |
Operating Cash Flow | -152.97M | -138.53M | -122.82M | -117.64M | -95.48M | -93.68M | -93.27M | -92.58M | -78.1M | -68.91M | -59.04M | -43.77M | -46.99M | -47.43M | -46.31M | -48.36M | -47.47M | -45.21M | -42.06M | -37.73M | -23.97M |
Capital Expenditures | -1.62M | -1.48M | -2.24M | -2.17M | -1.91M | -1.91M | -1.04M | -900.63K | -818K | -710K | -713K | -748K | -3.17M | -3.31M | -3.21M | -3.17M | -583K | -520K | -532.56K | -463.56K | -375.56K |
Cash Acquisitions | -24.01 | -24.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.31M | -958.58K | -958.58K |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -250K | -250K | -250K | -250K |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 7.34K | 7.34K | 7.34K | 7.34K | n/a | -207K | 7.43M | 7.43M | 7.43M | 7.63M | n/a | n/a | -66K | -174K | -318K | -385K | -415K | -395.71K | -258.71K | -191.71K |
Investing Cash Flow | -1.62M | -1.47M | -2.24M | -2.17M | -1.9M | -1.91M | -1.04M | 6.73M | 6.81M | 6.92M | 6.92M | -748K | -3.17M | -3.31M | -3.21M | -3.17M | -583K | -770K | -2.09M | -1.67M | -1.58M |
Debt Repayment | -20.19M | 12.47M | 12.53M | 32.55M | 32.46M | -269.05K | -362.05K | -301.57K | -212K | -149K | -56K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -300.68K | -300.68K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 116.59K | 116.59K | 610.59K | 983.22K | 667.35K | 558.35K | 64.35K | -331.21K | -53K | 56K | 56K | n/a | 48K | 362K | 430K | 1.83M | 4.26M | 4.27M | 10.58M | 9.59M | 7.12M |
Financial Cash Flow | 188.38M | 183.12M | 204.75M | 60.94M | 60.53M | 20.26M | 190.14M | 230.06M | 250.82M | 254.51M | 68.79M | 32.51M | 16.77M | 13.56M | 8.49M | 6.43M | 35.76M | 35.78M | 67.75M | 110.74M | 76.76M |
Net Cash Flow | 33.95M | 43.74M | 79.47M | -60.01M | -37.85M | -76.37M | 94.89M | 143.96M | 179.31M | 192.36M | 16.49M | -11.82M | -33.11M | -37.01M | -41.07M | -45.24M | -12.62M | -10.39M | 23.55M | 71.31M | 51.18M |
Free Cash Flow | -154.59M | -140.01M | -125.06M | -119.81M | -97.38M | -95.59M | -94.31M | -93.48M | -78.92M | -69.62M | -59.75M | -44.52M | -50.16M | -50.74M | -49.53M | -51.53M | -48.05M | -45.73M | -42.59M | -38.19M | -24.34M |
Adj. Free Cash Flow | -159.59M | -145.56M | -132.71M | -126.42M | -136.76M | -137.31M | -135.21M | -140.87M | -94.43M | -83.5M | -72.85M | -48.66M | -53.96M | -55.43M | -57.07M | -62.56M | -63.46M | -63.76M | -61.34M | -56.71M | -37.39M |
Maintenance CapEx | -123.21K | -120.89K | -1.17M | -1.46M | -1.76M | -1.91M | -1.04M | -900.63K | -818K | -710K | -713K | -748K | -3.17M | -3.31M | -3.21M | -3.17M | -583K | -520K | -532.56K | -463.56K | -375.56K |
Growth CapEx | -1.5M | -1.36M | -1.07M | -709.31K | -141.66K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -153.09M | -138.65M | -123.99M | -119.1M | -97.24M | -95.59M | -94.31M | -93.48M | -78.92M | -69.62M | -59.75M | -44.52M | -50.16M | -50.74M | -49.53M | -51.53M | -48.05M | -45.73M | -42.59M | -38.19M | -24.34M |
Add to Watchlist
Select watchlists to add or remove HELP